These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22103870)

  • 1. Uncontrolled hypertension: highlights and perspectives from the European Society of Hypertension Satellite Symposium.
    Pessina AC; Rossi GP
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1515-8. PubMed ID: 22103870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension.
    Volpe M
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S1. PubMed ID: 26153400
    [No Abstract]   [Full Text] [Related]  

  • 3. Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension, June 13-16, 2014 Athens, Greece. Introduction.
    Redon J
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S3-4. PubMed ID: 25929685
    [No Abstract]   [Full Text] [Related]  

  • 4. Achieving Goal Blood Pressure.
    Laurent S
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S5-9. PubMed ID: 26002423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New recommendations of the ESH/ESC: smooth changes for the hypertensive patient].
    Waeber B; Wuerzner G
    Rev Med Suisse; 2013 Sep; 9(397):1639-42, 1644. PubMed ID: 24073476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant systemic hypertension.
    Al-Baba B
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):340-2. PubMed ID: 21451335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology.
    Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM
    J Hum Hypertens; 2016 Nov; 30(11):657-663. PubMed ID: 26818804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistant Hypertension: An Update.
    Calhoun DA; Schiffrin EL; Flack JM
    Am J Hypertens; 2019 Jan; 32(1):1-3. PubMed ID: 30407514
    [No Abstract]   [Full Text] [Related]  

  • 9. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistant hypertension: a practical clinical approach.
    Muxfeldt ES; de Souza F; Salles GF
    J Hum Hypertens; 2013 Nov; 27(11):657-62. PubMed ID: 23636008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.
    Mancia G; De Backer G; Dominiczak A; Cifkova R; Fagard R; Germano G; Grassi G; Heagerty AM; Kjeldsen SE; Laurent S; Narkiewicz K; Ruilope L; Rynkiewicz A; Schmieder RE; Boudier HA; Zanchetti A;
    J Hypertens; 2007 Sep; 25(9):1751-62. PubMed ID: 17762635
    [No Abstract]   [Full Text] [Related]  

  • 12. Summary and Conclusions.
    Bakris G
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S23. PubMed ID: 26149526
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing Treatment-Resistant Patients.
    Schmieder RE
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S11-3. PubMed ID: 26025221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New Aspects and Controversies in the Current European and American Hypertension Guidelines].
    Nägele M; Sudano I; Flammer A; Ruschitzka F
    Praxis (Bern 1994); 2015 May; 104(11):575-80. PubMed ID: 26098154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension.
    Waeber B; Mourad JJ
    Am J Hypertens; 2006 Sep; 19(9):985-6. PubMed ID: 16942945
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with resistant hypertension have more peripheral arterial disease than other uncontrolled hypertensives.
    Korhonen PE; Kautiainen H; Kantola I
    J Hum Hypertens; 2015 Jan; 29(1):46-9. PubMed ID: 25078489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, prognosis, and treatment of resistant hypertension.
    Smith SM
    Pharmacotherapy; 2013 Oct; 33(10):1071-86. PubMed ID: 23722533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Why and when to begin pharmacological treatment with dual-therapy].
    Martell Claros N; Prieto Díaz MA
    Semergen; 2012 Oct; 38(7):445-51. PubMed ID: 23021577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy in the treatment of hypertension.
    Escobar C; Barrios V
    Fundam Clin Pharmacol; 2010 Feb; 24(1):3-8. PubMed ID: 19682088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching therapy to bedtime for uncontrolled hypertension with a nondipping pattern: a prospective randomized-controlled study.
    Farah R; Makhoul N; Arraf Z; Khamisy-Farah R
    Blood Press Monit; 2013 Aug; 18(4):227-31. PubMed ID: 23660686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.